Stocks to watch: TCS, Infosys, Ambuja Cements, Balrampur Chini, Castrol India, Tata Communications
Here is the list of top stocks that could be in focus on April 12.
Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could slump 212 points at the opening bell. The domestic equity benchmarks ended with small losses after a volatile session on Friday. The barometer index, the S&P BSE Sensex, declined 154.89 points or 0.31% to 49,591.32. The Nifty 50 index lost 38.95 points or 0.26% to 14,834.85. Foreign portfolio investors (FPIs) sold shares worth Rs 653.51 crore, while domestic institutional investors (DIIs), were also net sellers to the tune of Rs 271.26 crore in the domestic equity market on 9 April, provisional data showed. Here is the list of top stocks that could be in focus on April 12.
Earnings today: Tata Consultancy Services, Housing Development and Infrastructure and California Software to announce their March quarter results on Monday.
Infosys: The board of Infosys to meet on Wednesday to consider a proposal for buyback of fully paid-up equity shares of the company.
Ambuja Cements: The company at its AGM said that it is on track to expand capacity to reach 50 MTPA. Its upcoming facilities in Marwar Mundwa, Rajasthan, will enhance clinker capacity by 3 MTPA and improve cement sales by 5 MTPA. The greenfield integrated plant, which will involve a total investment of Rs 2,350 crore, will commence operations by Q3CY21.
Balrampur Chini: The board of Balrampur Chini approved revised capex for the 320 KLPD Distillery Plant to Rs 425 crore from the earlier approval of Rs 320 crore.
Castrol India: The company has entered into an exclusive supply arrangement with ki Mobility Solutions in India wherein Castrol will supply lubricant products to ki Mobility’s multi-brand workshops.
CreditAccess Grameen: Disbursements up 42.1% year-on-year and 2.8% quarter-on-quarter to Rs 4,413 crore. Active Borrowers up 4.4% quarter-on-quarter and 2% year-on-year to 29.63 lakh. 84.8% of FY21 disbursements happened during H2FY21.
Natco Pharma: The company’s marketing and distribution partner Alvogen Pine Brook LLC, has received tentative approval for its Abbreviated New Drug Application for Ibrutinib Tablets 560mg, 420mg, 280mg and 140mg strengths (generic for IMBRUVICA®), from the USFDA.
Tata Communications: Tata Communications and Bahrain Internet Exchange (BIX), its exclusive cable landing partner in Bahrain, extend their partnership to offer high-speed internet connectivity with very low latency for a superior quality and seamless viewing, gaming and download experience for customers in Bahrain.
Westlife Development: In wake of the new restrictions announced to curb the spread of Covid-19 infections in Maharashtra, Westlife Development Ltd owned – McDonald’s restaurants will operate contactless McDelivery till 3 am from select stores in Mumbai. The brand will further be doubling down on its convenience channels of McDelivery, takeaway and On the Go.
AU Small Finance Bank: The company gets approval from Reserve Bank of India for the reappointment of Raj Vikash Verma as part-time Chairman.
M&M: Mahindra & Mahindra (M&M) is planning to put fresh investments to the tune of Rs 3000 crore on its Electric Vehicles (EV) business in the next three years, while it looks for more alliances and partnerships in the vertical. The company is working on developing on an EV platform by combining capabilities of its operations across the globe, including Detroit and Italy.
Titan: Titan Company’s subsidiary company — Tanishq has unveiled a new brand proposition for its wedding exclusive sub-brand ‘Rivaah’ – Jewel for every tradition. The new proposition from Rivaah by Tanishq communicates the meaning and significance of every ritual and jewellery the bride wears. Even as there is a general nervousness in the gems and jewellery industry about the Covid related restrictions in Maharashtra impacting the wedding season demand, Tanishq is betting big on the rest of the markets for the wedding jewellery.
Natco Pharma: The company’s marketing and distribution partner — Alvogen Pine Brook LLC, has received tentative approval for Abbreviated New Drug Application (ANDA) Ibrutinib Tablets 560mg, 420mg, 280mg and 140mg strengths (generic for Imbruvica), from the U.S. Food and Drug Administration (USFDA).
Transwarranty Finance: The company has raised Rs 25 lakh through Secured Redeemable Non Convertible Debentures (NCDs) under Thirteenth Tranche/Series M/2020-21, on private placement basis.